STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

SAGE BIONETWORKS: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
SAGE BIONETWORKS (EIN 26-4489946)
Tax period
2015-01-01 to 2015-12-31
Filed
2016-11-11
IRS object ID
201633169349303773
Schema version
2015v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2016-11-11T13:45:27-07:00ReturnTs
Tax Period End2015-12-31TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2015-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN264489946EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SAGE BIONETWORKSBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlSAGEBusinessNameControlTxt
Phone2066672102PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11100 Fairview Ave NAddressLine1Txt
CitySeattleCityNm
State AbbreviationWAStateAbbreviationCd
ZIP98109ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonLara MangravitePersonNm
Person TitlePresidentPersonTitleTxt
Phone2066672102PhoneNum
Signature2016-11-11SignatureDt
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2017-02-10 21:41:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerLara MangravitePrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11100 Fairview Ave NAddressLine1Txt
Address Line2M1-C108AddressLine2Txt
CitySeattleCityNm
State AbbreviationWAStateAbbreviationCd
ZIP98109ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$7,695,817GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.sagebase.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2009FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionSage Bionetworks is a strategic research organization with a mission to coordinate and link academic and commercial biomedical researchers, patients and citizens through a Commons that represents a new paradigm for genomics intellectual property, researcher cooperation and contributor evolved resources. This mission has several interdependent themes, including: conducting research on network models of disease; building the computational platform for the Commons; and activating public engagement.ActivityOrMissionDesc
Voting Members Governing Body6VotingMembersGoverningBodyCnt
Voting Members Independent5VotingMembersIndependentCnt
Total Employee46TotalEmployeeCnt
Total Volunteers6TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$7,808,314PYContributionsGrantsAmt
CY Contributions Grants$6,230,208CYContributionsGrantsAmt
PY Program Service Revenue$1,552,869PYProgramServiceRevenueAmt
CY Program Service Revenue$1,464,553CYProgramServiceRevenueAmt
PY Investment Income$1,802PYInvestmentIncomeAmt
CY Investment Income$1,056CYInvestmentIncomeAmt
PY Other Revenue$18,940PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$9,381,925PYTotalRevenueAmt
CY Total Revenue$7,695,817CYTotalRevenueAmt
PY Grants And Similar Paid$230,351PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$411,920CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$5,801,106PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$5,824,396CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$54,163CYTotalFundraisingExpenseAmt
PY Other Expenses$1,412,793PYOtherExpensesAmt
CY Other Expenses$2,142,861CYOtherExpensesAmt
PY Total Expenses$7,444,250PYTotalExpensesAmt
CY Total Expenses$8,379,177CYTotalExpensesAmt
PY Revenues Less Expenses$1,937,675PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$683,360CYRevenuesLessExpensesAmt
Total Assets BOY$5,497,513TotalAssetsBOYAmt
Total Assets EOY$4,810,343TotalAssetsEOYAmt
Total Liabilities BOY$1,005,378TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,001,568TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$4,492,135NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$3,808,775NetAssetsOrFundBalancesEOYAmt
MissionSage Bionetworks is a strategic research organization with a mission to coordinate and link academic and commercial biomedical researchers, patients and citizens through a Commons that represents a new paradigm for genomics intellectual property, researcher cooperation and contributor evolved resources. This mission has several interdependent themes, including: conducting research on network models of disease; building the computational platform for the Commons; and activating public engagement. Sage Bionetworks is a non-profit research organization that seeks to develop predictors of disease and accelerate health research through the creation of open systems, incentives, and standards. We create strategies and platforms that empower researchers to share and interpret data on a colossal scale, crowdsource tests for new hypotheses, and contribute to knowledge through community challenges.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$5,768,003ExpenseAmt
Grant$4,160,784GrantAmt
Revenue$5,765,096RevenueAmt
DescResearch Communities and Challenges: Sage Bionetworks conducts research independently as well as with collaborators worldwide across a variety of disease areas. We work to redefine how complex biological data is gathered, shared and used through open systems, incentives, and norms. Our work includes the building of platforms and services and undertaking research developing predictors relating to health. In 2015, Sage was engaged in over 30 active federal research projects, and nearly 50 projects overall. Research Communities active in 2015 included the following: The AMP AD Knowledge Portal is a premier repository and workspace for multi-omic data generated through the AMP-AD consortia - a public private partnership, with the goal of accelerating the development of new drugs for the treatment and prevention of Alzheimer's disease. Data was first publically released starting in March 2015. The Colorectal Cancer Consortium is a collection of colorectal cancer researchers and data scientists from 15 academic, pharmaceutical, and non-profit partners, which represents the first effort to generate consensus cancer, subtypes, taking a major step toward precision medicine in CRC. The CommonMind Consortium is a Public-Private Pre-Competitive partnership with the goal to generate and analyze large-scale genomic data from human subjects with neuropsychiatric disease and to make this data and the analytical results broadly available. March 2015 marked the first data release. The Infectious Disease Resilience project is designed to identify common characteristics of individuals that are resilient to infectious disease as a mechanism to understand the underlying biology. The mPower Public Researcher Portal is the data access point for the mobile app-based study piloting new approaches to monitoring key indicators of Parkinson Disease progression and diagnosis. The Progenitor Cell Biology Consortium (PCBC) is an NIH sponsored effort to identify and characterize progenitor cell lineages and to develop new strategies related to the transplantation of these cells. The goal of the PsychENCODE Consortium is a public, comprehensive, and integrated resource of human brain data with a focus on autism, mood disorders, and psychoses. Data generated by the Consortium will be disseminated to the public starting in 2016. The Synodos Consortium is a first-of-its-kind Nuerofibromatosis research collaboration dedicated to defeating the rare genetic disorder neurofibromatosis type 2. With data from 12 cancers The Cancer Genome Atlas (TCGA) is an effort to simultaneously analyze molecular platforms for patterns across cancer types. Working in Synapse this group created a common data resource and made results available through 18 published papers. In 2013, Sage partnered with DREAM (http://www.the-dream-project.org/), to host open computational challenges designed and run by a community of researchers from a variety of organizations, and with a solver community of more than 15,000 individuals. DREAM Challenges invite participants to propose solutions to fundamental questions about systems biology and translational medicine - fostering collaboration and building communities in the process. Sage's Challenges leverage the "wisdom of the crowd" to find new and better computational models and make these methods available to all. Active Challenges in 2015 included ALS Stratification Prize4Life DREAM Challenge - focuses on predicting the progression and survival of ALS patients. This effort will also work to significantly reduce the costs of future ALS clinical trials, aid clinical care and identify new disease predictors that can lead to novel biomarker development. AstraZeneca Drug Combination Prediction DREAM Challenge - designed to explore fundamental traits that underlie effective combination treatments and synergistic drug behavior using baseline genomic data. ICGC-TCGA Somatic Mutation Calling -Tumor Heterogeneity DREAM Challenge - an international effort to improve standard methods for subclonal reconstruction to quantify and genotype each individual cell population present within a tumor.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,980,883ExpenseAmt
Grant$0GrantAmt
Revenue$1,661,123RevenueAmt
DescSage Bionetworks Mobile Health (mHealth): In 2013, Sage expanded efforts in citizen engagement with the development of Bridge, a cloud-based collaborative science platform designed to incorporate open data, patient wisdom and public involvement into biomedical research. Bridge is a key piece of IT infrastructure essential for empowering citizens to share and track their data, to partner on research and to fund the projects that matter most to them. On Bridge, citizens, patients and researchers are able to use online tools that connect people, their data and their stories to build online communities focused on defining the disease or health research that matters most to patients and their families. With the 2015 launch of Apple's open source ResearchKit platform, Sage Bionetworks has been an integral partner in the design, development and launch of smartphone-enabled clinical studies across multiple disease areas. mHealth services include: software engineering for app design and development, data governance for e-consent and IRB submission and IRB-approved cloud-based infrastructure (Bridge Server) for study data collection, de-identification and hosting. In 2015, Sage launched the first two mobile app-based research studies on Bridge as part of Apple's ResearchKit. Enrollment in the Parkinson's mPower Study and the Share the Journey Breast Cancer Survivor Study opened in March 2015. The Parkinson's mPower Study uses microphone, accelerometer, and touch-screen sensors in a mobile app to measure fluctuations in gait, posture, voice, and manual dexterity, and explores correlations with environmental factors such as sleep and exercise. The Share the Journey Breast Cancer Survivor Study is designed to look at the long-term side effects of chemotherapy on mood, cognitive function, and energy level, exploring the intersection of these experiences with environmental factors to learn how symptoms can be more effectively managed. Active Challenges in 2015 included:ALS Stratification Prize4Life DREAM Challenge - focuses on predicting the progression and survival of ALS patients. This effort will also work to significantly reduce the costs of future ALS clinical trials, aid clinical care and identify new disease predictors that can lead to novel biomarker development. AstraZeneca Drug Combination Prediction DREAM Challenge - designed to explore fundamental traits that underlie effective combination treatments and synergistic drug behavior using baseline genomic data. ICGC-TCGA Somatic Mutation Calling -Tumor Heterogeneity DREAM Challenge - an international effort to improve standard methods for subclonal reconstruction to quantify and genotype each individual cell population present within a tumor.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$0TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$7,748,886TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document5IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee46EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members6GoverningBodyVotingMembersCnt
Independent Voting Member5IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention Policy0DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonDiane GaryPersonNm
Phone2066673038PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11100 Fairview Ave NAddressLine1Txt
CitySeattleCityNm
State AbbreviationWAStateAbbreviationCd
ZIP98109ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Stephen Friend
President/Director500Yes (X)Yes (X)$240,416$0$15,122
Eric Schadt
Director/Chair of Scientific Advisory Board10Yes (X)$0$0$0
Jeff Hammerbacher
Director10Yes (X)$0$0$0
Tony Ford-Hutchinson
Director10Yes (X)$0$0$0
Gustavo Stolovitsky
Director10Yes (X)$0$0$0
Eric Topol
Director10Yes (X)$0$0$0
Diane Gary
Secretary500Yes (X)$156,025$0$25,961
Mike Kellen
Director, Technology & Software Development500$182,601$0$23,773Yes (X)
John Wilbanks
Chief Commons Officer500$220,325$0$34,228Yes (X)
Thea Norman
Director, Strategic Development500$170,523$0$34,557Yes (X)
Lara Mangravite
Director, Systems Biology500$160,948$0$28,770Yes (X)
Arno Klein
Principal Scientist500$153,991$0$19,351Yes (X)
Justin Guinney
Director, Oncology500$152,542$0$30,769Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,437,371TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$212,531TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K26IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Federated Campaigns$0FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$0FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$3,549,664GovernmentGrantsAmt
All Other Contributions$2,680,544AllOtherContributionsAmt
Noncash Contributions$93,459NoncashContributionsAmt
Total Contributions$6,230,208TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescCollaboratorsDesc
Business541711BusinessCd
Total Revenue Column$1,464,553TotalRevenueColumnAmt
Related Or Exempt Func Income$1,464,553RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$1,464,553TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,056TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,056ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$0SecuritiesAmt
Other$0OtherAmt
FieldValueIRS element (for citing)
Contri Rpt Fundraising Event$0ContriRptFundraisingEventAmt
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,695,817TotalRevenueColumnAmt
Related Or Exempt Func Income$1,464,553RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,056ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$331,398TotalAmt
Program Services$331,398ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$80,522TotalAmt
Program Services$80,522ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$677,878TotalAmt
Program Services$391,657ProgramServicesAmt
Management And General$270,249ManagementAndGeneralAmt
Fundraising$15,972FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$4,423,427TotalAmt
Program Services$4,229,511ProgramServicesAmt
Management And General$168,628ManagementAndGeneralAmt
Fundraising$25,288FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$287,842TotalAmt
Program Services$267,039ProgramServicesAmt
Management And General$20,247ManagementAndGeneralAmt
Fundraising$556FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$149,728TotalAmt
Program Services$120,122ProgramServicesAmt
Management And General$24,400ManagementAndGeneralAmt
Fundraising$5,206FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$285,521TotalAmt
Program Services$260,620ProgramServicesAmt
Management And General$24,193ManagementAndGeneralAmt
Fundraising$708FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$68,057TotalAmt
Program Services$61,891ProgramServicesAmt
Management And General$5,636ManagementAndGeneralAmt
Fundraising$530FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$119,533TotalAmt
Program Services$119,533ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$34,654TotalAmt
Program Services$34,654ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt
Fundraising$0FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,111,552TotalAmt
Program Services$1,110,740ProgramServicesAmt
Management And General$742ManagementAndGeneralAmt
Fundraising$70FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$588TotalAmt
Program Services$588ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$28,208TotalAmt
Program Services$25,652ProgramServicesAmt
Management And General$2,336ManagementAndGeneralAmt
Fundraising$220FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$52,752TotalAmt
Program Services$48,480ProgramServicesAmt
Management And General$3,905ManagementAndGeneralAmt
Fundraising$367FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$374,786TotalAmt
Program Services$340,833ProgramServicesAmt
Management And General$31,035ManagementAndGeneralAmt
Fundraising$2,918FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$237,411TotalAmt
Program Services$216,386ProgramServicesAmt
Management And General$19,218ManagementAndGeneralAmt
Fundraising$1,807FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$24,772TotalAmt
Program Services$22,528ProgramServicesAmt
Management And General$2,051ManagementAndGeneralAmt
Fundraising$193FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$9,083TotalAmt
Program Services$8,260ProgramServicesAmt
Management And General$752ManagementAndGeneralAmt
Fundraising$71FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$19,807TotalAmt
Program Services$18,013ProgramServicesAmt
Management And General$1,640ManagementAndGeneralAmt
Fundraising$154FundraisingAmt

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$61,658TotalAmt
Program Services$60,459ProgramServicesAmt
Management And General$1,096ManagementAndGeneralAmt
Fundraising$103FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$8,379,177TotalAmt
Program Services$7,748,886ProgramServicesAmt
Management And General$576,128ManagementAndGeneralAmt
Fundraising$54,163FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,987,176BOYAmt
EOY$866,729EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$3,319,126BOYAmt
EOY$3,509,569EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$79,316BOYAmt
EOY$367,983EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$42,277BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$29,074BOYAmt
EOY$54,082EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$62,146LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$50,166LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$40,544BOYAmt
EOY$11,980EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,497,513BOYAmt
EOY$4,810,343EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$496,748BOYAmt
EOY$490,503EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$508,630BOYAmt
EOY$511,065EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,005,378BOYAmt
EOY$1,001,568EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$814,142BOYAmt
EOY$361,382EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,677,993BOYAmt
EOY$3,447,393EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,492,135BOYAmt
EOY$3,808,775EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,497,513BOYAmt
EOY$4,810,343EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$683,360ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$0NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewYes (1)AccountantCompileOrReviewInd

Acct Compile Or Review Basis AcctCompileOrReviewBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,717,790CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,014,681CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,154,616CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,808,314CurrentTaxYearMinus1YearAmt
Current Tax Year$6,230,203CurrentTaxYearAmt
Total$27,925,604TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,717,790CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,014,681CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,154,616CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,808,314CurrentTaxYearMinus1YearAmt
Current Tax Year$6,230,203CurrentTaxYearAmt
Total$27,925,604TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$0SubstantialContributorsTotAmt
Public Support Total170$27,925,604PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,702CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,146CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,640CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,802CurrentTaxYearMinus1YearAmt
Current Tax Year$1,056CurrentTaxYearAmt
Total$9,346TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,088,987CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,766,523CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,531,308CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,552,869CurrentTaxYearMinus1YearAmt
Current Tax Year$1,464,542CurrentTaxYearAmt
Total$8,404,229TotalAmt
FieldValueIRS element (for citing)
Total Support$36,339,179TotalSupportAmt
Gross Receipts Rltd Activities$0GrossReceiptsRltdActivitiesAmt
Public Support CY1700.76847PublicSupportCY170Pct
Public Support PY1700.7018PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part II, Line 10FormAndLineReferenceDesc
ExplanationFee for Service Revenue from research collaborations.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$62,146InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$50,166DepreciationAmt
Book Value$11,980BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$11,980TotalBookValueLandBuildingsAmt
Total Rev Etc Audited Fincl Stmt$7,695,817TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$0NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants$0RecoveriesPriorYearGrantsAmt
Other Revenue$0OtherRevenueAmt
Revenue Not Reported$0RevenueNotReportedAmt
Revenue Subtotal$7,695,817RevenueSubtotalAmt
Investment Expenses Not Incld$0InvestmentExpensesNotIncldAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$7,695,817TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$8,379,177TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$0DonatedServicesUseFcltsAmt
Prior Year Adjustments$0PriorYearAdjustmentsAmt
Losses Reported$0LossesReportedAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$8,379,177ExpensesSubtotalAmt
Investment Expenses Not Incld2$0InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$8,379,177TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionEurope (including Iceland and Greenland)RegionTxt
Offices0OfficesCnt
Employee0EmployeeCnt
Type Of Activities ConductedGrantmakingTypeOfActivitiesConductedTxt
Specific Services ProvidedData generation for our Coordinated Pediatric AML Treatment Options project.SpecificServicesProvidedTxt
Region Total Expenditures$80,522RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Total Spent$80,522TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEurope (including Iceland and Greenland)RegionTxt
Purpose Of GrantData generation for our Coordinated Pediatric AML Treatment Options project.PurposeOfGrantTxt
Cash Grant$80,522CashGrantAmt
Manner Of Cash DisbursementElectronic Fund TransferMannerOfCashDisbursementTxt
Non Cash Assistance$0NonCashAssistanceAmt
FieldValueIRS element (for citing)
Total501c3 Org0Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 2FormAndLineReferenceDesc
ExplanationMonitoring the use of grant funds: In some cases, grants received by Sage Bionetworks are passed on to sub-recipients through a sub-award agreement. The Grant Manager is responsible for initiating the sub-award agreement after obtaining budget approval from the PI and Operations Director. In issuing a sub-award, the Grant Manager is responsible for: obtaining verification of the sub-awardee's facilities and administrative rates and Single Audit Reports; reviewing the prime award special terms and conditions to determine whether they are applicable to the sub-award; and determining whether the sub-awardee meets all of the other administrative and regulatory requirements of the prime award. Once the sub-award has been issued, the Grant Manager is responsible for monitoring sub-award activity, including compliance with all reporting requirements. The Grant Manager is also responsible for forwarding the fully executed sub-award documents to the Accounting Manager to ensure proper billing. Payments are made only after the sub-award agreement has been fully executed by both parties.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (6 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
Fred Hutchinson Cancer Research Center
1100 Fairview Ave NSeattleWA98109237156071$62,887Assist in the high throughput drug screening and genomic profiling of patients at relapse to define patient specific drug sensitivity profile and their genomic/transcript composition for our Coordinated Pediatric AML Treatment Options project.
Oregon Health Sciences University
3181 SW Sam Jackson Park RdPortlandOR97239931176109$100,166Validate and assimilate data from functional and genomic data to facilitate their use in the cancer cloud hub, provide bioinformatics analyses and algorithm design to aid in the development of real-time models to predict treatment outcomes based on integrated data for each patient for our Coordinated Pediatric AML Treatment Options project.
Phoenix Children's Hospital
1919 E Thomas RoadPhoenixAZ85016742421549$93,967Perform drug screening, molecular integration of data and clinical trial development as well as analysis and transfer of the large genomic data sets that will be integrated by the bioinformatical teams at each participating institution for our Coordinated Pediatric AML Treatment Options project.
Institute for Medical Research Inc
508 Fulton StDurhamNC27705561655431$49,295Project development, data curation, pilot analyses, develop open innovation challenge to crowd source study design, and build a collaborative working group from participants and organizers for our "Resilience to Infection: an open innovation challenge to the community" project.
University of South Alabama
307 N University Blvd No 130MobileAL36608630477348$13,334Provide data analyses for our "Resilience to Infection: an open innovation challenge to the community" project.
Group Health Research Institute
1730 Minor Ave Suite 1600SeattleWA98101910511770$11,749Data/image generation for our Digital Mammography Challenge project.
FieldValueIRS element (for citing)
Total501c3 Org6Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2FormAndLineReferenceDesc
ExplanationIn 2015, Sage Bionetworks issued grants, contributions, and prizes. Contributions were given in support of an awarded institution's project and prizes were awarded to research challenge winners. Monitoring the use of grant funds: In some cases, grants received by Sage Bionetworks are passed on to sub-recipients through a sub-award agreement. The Grant Manager is responsible for initiating the sub-award agreement after obtaining budget approval from the PI and Operations Director. In issuing a sub-award, the Grant Manager is responsible for: obtaining verification of the sub-awardee's facilities and administrative rates and Single Audit Reports; reviewing the prime award special terms and conditions to determine whether they are applicable to the sub-award; and determining whether the sub-awardee meets all of the other administrative and regulatory requirements of the prime award. Once the sub-award has been issued, the Grant Manager is responsible for monitoring sub-award activity, including compliance with all reporting requirements. The Grant Manager is also responsible for forwarding the fully executed sub-award documents to the Accounting Manager to ensure proper billing. Payments are made only after the sub-award agreement has been fully executed by both parties.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (1)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Stephen Friend
President/Director$240,416$0$0$0$0$0$0$0$15,122$0$255,538$0$0$0
John Wilbanks
Chief Commons Officer$220,325$0$0$0$0$0$0$0$34,228$0$254,553$0$0$0
Mike Kellen
Director, Technology & Software Development$182,601$0$0$0$0$0$0$0$23,773$0$206,374$0$0$0
Thea Norman
Director, Strategic Development$170,523$0$0$0$0$0$0$0$34,557$0$205,080$0$0$0
Lara Mangravite
Director, Systems Biology$160,948$0$0$0$0$0$0$0$28,770$0$189,718$0$0$0
Justin Guinney
Director, Oncology$152,542$0$0$0$0$0$0$0$30,769$0$183,311$0$0$0
Diane Gary
Secretary$156,025$0$0$0$0$0$0$0$25,961$0$181,986$0$0$0
Arno Klein
Principal Scientist$153,991$0$0$0$0$0$0$0$19,351$0$173,342$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1aAll travel is conducted per the company travel policy.
Schedule J, Part I, Line 3Setting executive compensation is the responsibility of the Board of Directors Compensation Committee.

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I, Line 33FormAndLineReferenceDesc
ExplanationReceived In-Kind legal services.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Section B, Line 11bThe 990 is reviewed by the company's Director of Operations and President prior to filing.
Form 990, Part VI, Section B, Line 12cSage Bionetworks has a Financial Conflict of Interest Policy (FCOI) that complies with the National Institutes of Health-specific requirements promoting objectivity in research, 42 CFR Part 50 subpart F. On an annual basis, Sage Bionetworks Officers, Directors and members of committees of the Board of Directors authorized to act on behalf of the board, and employees designated by the President of Sage Bionetworks, including any employees serving as an investigator on a federal/Public Health Services award, must complete the Sage Bionetworks Annual Conflict of Interest Questionnaire. New Employees serving as investigators are required to complete a FCOI form within 30 days of their start date. In addition, all investigators must submit an ad hoc disclosure of any Significant Financial Interest they acquire or discover during the course of the year within 30 days of discovering or acquiring the Significant Financial Interest. Any reported conflicts are reviewed by the President and outside counsel.
Form 990, Part VI, Section B, Line 15Executive compensation was set by the Board of Directors Compensation Committee.
Form 990, Part VI, Section C, Line 19The organization's financials are contained within its 990 returns. These returns are available to the public through organizations such as Guidestar, dedicated to publicizing information about nonprofit organizations. The organization's governing documents and conflict of interest policies are available upon request.
Form 990, Part IX, Line 11gScientific Research Expenses $210,864; Commons/Assembly Expenses $570,971; Platform/Scientific Computing Expenses $298,770; Professional Services/Accounting $25,547; Fund Development $5,400